Literature DB >> 22124942

Iatrogenic heart block during treatment of a patient with Cushing's syndrome: report of a case.

J P Brito, E Singh, A Basu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22124942     DOI: 10.1007/s12020-011-9567-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  3 in total

1.  The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.

Authors:  Thorir D Bjornsson; John T Callaghan; Heidi J Einolf; Volker Fischer; Lawrence Gan; Scott Grimm; John Kao; S Peter King; Gerald Miwa; Lan Ni; Gondi Kumar; James McLeod; R Scott Obach; Stanley Roberts; Amy Roe; Anita Shah; Fred Snikeris; John T Sullivan; Donald Tweedie; Jose M Vega; John Walsh; Steven A Wrighton
Journal:  Drug Metab Dispos       Date:  2003-07       Impact factor: 3.922

2.  Ketoconazole inhibits corticotropic cell function in vitro.

Authors:  G K Stalla; J Stalla; M Huber; J P Loeffler; V Höllt; K von Werder; O A Müller
Journal:  Endocrinology       Date:  1988-02       Impact factor: 4.736

3.  Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil.

Authors:  Ying-Hong Wang; David R Jones; Stephen D Hall
Journal:  Drug Metab Dispos       Date:  2005-02-02       Impact factor: 3.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.